Endocrine Abstracts

Introduction: Denosumab discontinuation rapidly reverses bone turnover inhibition and eliminates anti-fracture protection. Multiple vertebral fractures (MVF) were reported in this scenario. Previously, we reported a retrospective real-life analysis designed to estimate fracture risk following denosumab discontinuation. Here we report a patient-level data of a subgroup with MVF.Methods: Via computerized database of Maccabi Healthcare Services, persistent ...